Children born small for gestational age (SGA) exhibited impaired glucose-insulin metabolism, similar to children with obesity, which worsened under growth hormone therapy. In contrast, children with ...
Explore new strategies for treating resistant lung cancer. Discover how blocking growth hormone receptors may improve ...
Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other ...
Ohio University researchers have discovered what may be a new way to fight lung cancer that is resistant to other treatments.
Ninety-five percent of adolescent athletes with lumbar spine stress fractures recovered without surgery, according to research from New York City-based Hospital for Special Surgery presented at the ...
Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya® (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...
Sermorelin.com Unveils Telehealth Peptide Treatment for Lean Mass Preservation Sheridan, United States - February 27, ...
Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya (R) (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...
News-Medical.Net on MSN
Blocking growth hormone receptor may improve treatment response in lung cancer
Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other treatments. The study published in the International Journal of Molecular Science ...
HSS Presents New Findings Impacting Pediatric Orthopedic Care Recommendations at AAOS Annual Meeting
At this year's American Academy of Orthopedic Surgeons (AAOS) annual meeting, investigators at Hospital for Special Surgery (HSS) presented several significant studies, two of which could lead to ...
Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other treatments. The study published ...
Sermorelin.com, a telehealth platform specializing in physician-supervised peptide therapy, today announced the launch of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results